Faculty | Infectious Diseases Division

Marissa B Wilck, MBChB, MS,

Assistant Professor of Clinical Medicine

Attending Physician, Hospital of the University of Pennsylvania

Department: Medicine

Contact information

Hospital of the University of Pennsylvania
502 Johnson Pavilion
36th Street & Hamilton Walk
Philadelphia, PA 19104

Office: 215 573 8432

Email:
marissa.wilck@uphs.upenn.edu

Education:
MBChB (Medical Doctor)
University of Cape Town, South Africa, 1996.
DTM&H (Diploma in Tropical Medicine and Hygiene)
London School of Tropical Medicine and Hygiene. London, UK., 1999.
M.S. (Masters in Health Sciences and Technology)
Harvard/MIT Division of Health Sciences and Technology, Beth Israel Deaconess Medical Center, Boston, MA, 2010.

Post-Graduate Training
Intern in Medicine, Groote Schuur Hospital, Cape Town, South Africa, 1997-1997.
Fellow in Clinical Microbiology, Yale New Haven Hospital, New Haven, CT, 1999-2000.
Intern in Medicine, Georgetown Program at the Washington Hospital Center, Washington, DC, 2000-2001.
Resident in Medicine, Georgetown Program at the Washington Hospital Center, Washington, DC, 2001-2003.
Chief Resident in Medicine, Georgetown Program at the Washington Hospital Center, Washington, DC, 2003-2004.
Clinical Fellow in Medicine, Harvard Medical School Boston, MA, 2004-2005.
Clinical and Research Fellow in Infectious Diseases, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA, 2004-2006.

Certifications
Board Certified in Internal Medicine ABIM, 2004.
Board Certified in Infectious Diseases ABIM, 2006.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Kharfan-Dabaja Mohamed A, Boeckh Michael, Wilck Marissa B, Langston Amelia A, Chu Alice H, Wloch Mary K, Smith Larry R, Rolland Alain P, Kenney Richard T: Reanalysis of TransVax immunogenicity. The Lancet infectious diseases 13(1): 18, Jan 2013.

Wilck MB and Blumberg EA: Donor Derived Infections. Textbook of Organ Transplantation. John Wiley & Sons Ltd 2013 Notes: Accepted for publication.

Oxman DA and Wilck MB: Community Aquired Pneumonia The Intensive Care Unit Manual, Second Edition. Paul N. Lanken, MD, C. William Hanson, III, MD and Scott Manaker, MD, PhD (eds.). Elsevier, 2013 Notes: Accepted for publication.

Daniel R Stevens, Pharm D, Jennifer Trofe-Clark, Pharm D1, Emily Blumberg, MD, Marissa Wilck, MD, Blair Weikert, MD, Simin Goral, MD, Melissa Bleicher, MD, Deirdre Sawinski, MD, Peter Abt, MD, Ali Naji, MD,PhD, Matthew Levine, MD,PhD, Paige Porrett, MD,PhD and Roy D Bloom, MD. : Increased Risk of Breakthrough Infection Among Cytomegalovirus Donor Positive/Recipient Negative Kidney Transplant Recipients Receiving Lower Dose Valganciclovir Prophylaxis. American Transplant Congress (ATC) at the Washington State Convention Center, May 18-22, 2013. 2013.

Wine-Lee L, Keller S, Wilck MB, Gluckman S, VanVorhees A : Vaccinations in adult patients on systemic therapy for psoriasis. Journal of the American Academy of Dermatology 2013 Notes: Accepted for publication.

Zuckerman R, Wilck MB and the AST Infectious Diseases Community of Practice: Herpes Simplex Virus Infections. American Journal of Transplantation Allan D. Kirk (eds.). 2013 Notes: Accepted for publication.

Kharfan-Dabaja Mohamed A, Boeckh Michael, Wilck Marissa B, Langston Amelia A, Chu Alice H, Wloch Mary K, Guterwill Don F, Smith Larry R, Rolland Alain P, Kenney Richard T: A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases 12(4): 290-9, Apr 2012.

Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R.: Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration. Journal Infectious Diseases Page: 1361-1370, May 2010.

Seaman Michael S, Wilck Marissa B, Baden Lindsey R, Walsh Stephen R, Grandpre Lauren E, Devoy Colleen, Giri Ayush, Noble Lizanne C, Kleinjan Jane A, Stevenson Kristen E, Kim Haesook T, Dolin Raphael: Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. Journal of Infectious Diseases 201(9): 1353-1360, May 2010.

Wilck Marissa B, Hamel Mary Beth, Baden Lindsey R: Clinical decisions. Management of incidental hepatitis C virus infection--polling results. The New England Journal of Medicine 360(23): e30, June 2009.